Financing, Equity Capital Markets

Catalyst Pharmaceuticals, Inc.

01/24
|
$150.0 Million
Catalyst
Piper Sandler served as bookrunner for Catalyst Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma